Residual cardiovascular (CV) risk persists despite achieving low-density lipoprotein cholesterol (LDL-C) targets with lipid-lowering therapy, indicating the role of other lipid parameters. Robust evidence has shown that non-high-density lipoprotein cholesterol... ...

请注册登录后继续浏览